Century Therapeutics, Inc. Profile Avatar - Palmy Investing

Century Therapeutics, Inc.

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent s…

Biotechnology
US, Philadelphia [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Century Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Century Therapeutics, Inc. has no acquisition track records yet.

End of IPSC's Analysis
CIK: 1850119 CUSIP: 15673T100 ISIN: US15673T1007 LEI: - UEI: -
Secondary Listings
IPSC has no secondary listings inside our databases.